Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial

J Michiel Zeeuw(Amsterdam Neuroscience), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Marinde J. G. Bond(Utrecht University), Cornelis Verhoef(Erasmus MC Cancer Institute), Inez M. Verpalen(Amsterdam Neuroscience), John J. Hermans(Erasmus MC), Janneke E. van den Bergh(Dutch Cancer Society), Nina J. Wesdorp(Vrije Universiteit Amsterdam), J.H.T. van Waesberghe(Amsterdam Neuroscience), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Jaap Stoker(University of Amsterdam), Mike S.L. Liem(Medisch Spectrum Twente), Susan van Dieren(Amphia Ziekenhuis), Shira Moos(Amsterdam Neuroscience), Mahsoem Ali(Vrije Universiteit Amsterdam), Gijs A. Patijn(Isala), Cornelis J.A. Punt(Utrecht University), Tineke E. Buffart(Amsterdam University Medical Centers), Wouter K. G. Leclercq(Radboud University Nijmegen), Michael F. Gerhards(Erasmus MC), Joost Huiskens(Amsterdam UMC Location University of Amsterdam), Ruby Kemna(Vrije Universiteit Amsterdam), Joost M. Klaase(University Medical Center Groningen), Dirk J. Grünhagen(Erasmus MC), Arjen M. Rijken(Amphia Ziekenhuis), Joran Roor, I. Quintus Molenaar(Utrecht University), Thomas van Gulik, Martinus J. van Amerongen(Sint Maartenskliniek), Krijn P. van Lienden(St. Antonius Ziekenhuis), Theo Ruers(The Netherlands Cancer Institute), Ronald M van Dam(Maastricht University Medical Centre), Johannes HW de Wilt(Radboud University Nijmegen), Irene M G C Nota(Amsterdam Neuroscience), Marc R W Engelbrecht(Amsterdam University Medical Centers), Koert P. de Jong(University of Padua), Niels F.M. Kok(The Netherlands Cancer Institute), T. Chapelle(Antwerp University Hospital)
European Journal of Cancer
August 21, 2025
Cited by 3


Related Papers